During the past decade, Centre Médical du Suivi des Donneurs de Sang (Blood Bank Medical Centre) conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Centre Médical du Suivi des Donneurs de Sang (Blood Bank Medical Centre)" are "HIV Infection" (1 trials) and "HIV-2 Infection" (1 trials). Many other conditions were trialed in "Centre Médical du Suivi des Donneurs de Sang (Blood Bank Medical Centre)" in a lesser frequency.

Most popular intervention types in "Centre Médical du Suivi des Donneurs de Sang (Blood Bank Medical Centre)" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Tenofovir + Emtricitabine or Lamivudine + Lopinavir/ritonavir" (1 trials), "Tenofovir + Emtricitabine or Lamivudine + Raltegravir" (1 trials) and "Tenofovir + Emtricitabine or Lamivudine + Zidovudine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre Médical du Suivi des Donneurs de Sang (Blood Bank Medical Centre)" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Centre Médical du Suivi des Donneurs de Sang (Blood Bank Medical Centre)". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Centre Médical du Suivi des Donneurs de Sang (Blood Bank Medical Centre), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centre Médical du Suivi des Donneurs de Sang (Blood Bank Medical Centre), 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".